MeSH tree: C19.391.630.705
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in Cancer Immunology Research the characterization of a novel therapeutic approach capable ...
Dec 11, 2023
0
69
MIT researchers have designed a wearable ultrasound monitor, in the form of a patch, that can image organs within the body without the need for an ultrasound operator or application of gel.
Nov 16, 2023
0
67
Four women have successfully had a combined surgery, in which they gave birth by cesarean section and at the same time had surgery to reduce their risk of ovarian cancer, thanks to a team of researchers and clinicians at ...
Nov 3, 2023
0
44
When Lindsey Huie arrived at the hospital that day in 2019, she had already hit peak stress.
Oct 18, 2023
0
29
Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress ...
Oct 18, 2023
0
51
Residing in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer, and multiple myeloma, ...
Oct 4, 2023
0
94
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can ...
Sep 21, 2023
0
72
September is Prostate Cancer Awareness Month. It's one of the leading causes of cancer death among all men. However, Black men are disproportionately hit hard by the disease. One in 6 Black men will develop prostate cancer ...
Sep 20, 2023
0
47
Millions of women are turning to the social media platform TikTok for health advice related to gynecologic cancers, but the majority of that information is misleading or dramatically inaccurate, according to a new study published ...
Sep 19, 2023
0
44
A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects. Targeting the ...
Sep 18, 2023
0
96
